Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Faculty Opinions recommendation of Irrigation versus suction alone during laparoscopic appendectomy for perforated appendicitis: a prospective randomized trial.
Mathis, Kellie L.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 19, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717958567.793464806 Get It

Faculty Opinions recommendation of Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis.
Mathis, Kellie L.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 19, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717958397.793464803 Get It

Faculty Opinions recommendation of A randomized controlled trial comparing colonic irrigation and oral antibiotics administration versus 4% formalin application for treatment of hemorrhagic radiation proctitis.
Mathis, Kellie L.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 19, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717958560.793464804 Get It

Stroke After Carotid Stenting and Endarterectomy in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Hill, Michael D. , Brooks, William H. , Mackey, Ariane , Clark, Wayne M. , Morrish, William, Mohr, J.P. , Rhodes, J. , Popma, Jeffrey J. , Lal, Brajesh K. , Longbottom, Mary, Voeks, Jenifer H. , Howard, George , Brott, Thomas G. , Investigators, for the CREST, Meschia, James F. , Investigators, for the CREST, Hill, Michael D , Howard, George

Circulation | November 18, 2012 | Volume: 126 | Issue: 25 | Pages: 3054-3061

10.1161/circulationaha.112.120030 | PMID 23159552 Get It

Background— Stroke occurs more commonly after carotid artery stenting than after carotid endarterectomy. Details regarding stroke type, severity, and characteristics have not been reported previously. We describe the strokes that have occurred in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Methods and Results— CREST is a randomized, open-allocation, controlled trial with blinded end-point adjudication. Stroke was a component of the primary composite outcome. Patients who received their assigned treatment within 30 days of randomization were included. Stroke was adjudicated by a panel of board-certified vascular neurologists with secondary central review of clinically obtained brain images. Stroke type, laterality, timing, and outcome were reported. A periprocedural stroke occurred among 81 of the 2502 patients randomized and among 69 of the 2272 in the present analysis. Strokes were predominantly minor (81%, n=56), ischemic (90%, n=62), in the anterior circulation (94%, n=65), and ipsilateral to the treated artery (88%, n=61). There were 7 hemorrhages, which occurred 3 to 21 days after the procedure, and 5 were fatal. Major stroke occurred in 13 (0.6%) of the 2272 patients. The estimated 4-year mortality after stroke was 21.1% compared with 11.6% for those without stroke. The adjusted risk of death at 4 years was higher after periprocedural stroke (hazard ratio, 2.78; 95% confidence interval, 1.63–4.76). Conclusions— Stroke, particularly severe stroke, was uncommon after carotid intervention in CREST, but stroke was associated with significant morbidity and was independently associated with a nearly 3-fold increased future mortality. The delayed timing of major and hemorrhagic stroke after revascularization suggests that these strokes may be preventable. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00004732.
Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis
Masterson, Joanne C. , McNamee, Eóin N. , Hosford, Lindsay , Ruybal, Joseph, Fillon, Sophie, Doyle, Alfred D. , Rustgi, Anil K. , Protheroe, Cheryl, Lee, Nancy A., Lee, James J. , Furuta, Glenn T. , Capocelli, Kelley E. , Eltzschig, Holger K.

Gut | November 17, 2012 | Volume: 63 | Issue: 1 | Pages: 43-53

10.1136/gutjnl-2012-303631 | PMID 23161496 Get It

Objective Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition of the oesophagus with limited treatment options. No previous transgenic model has specifically targeted the oesophageal mucosa to induce oesophageal eosinophilia. Design We developed a mouse model that closely resembles EoE by utilising oxazolone haptenation in mice with transgenic overexpression of an eosinophil poietic and survival factor (interleukin (IL)-5) in resident squamous oesophageal epithelia. Results Overexpression of IL-5 in the healthy oesophagus was achieved in transgenic mice ( L2-IL5 ) using the squamous epithelial promoter Epstein–Barr virus ED-L2. Oxazolone-challenged L2-IL5 mice developed dose-dependent pan-oesophageal eosinophilia, including eosinophil microabscess formation and degranulation as well as basal cell hyperplasia. Moreover, oesophagi expressed increased IL-13 and the eosinophil agonist chemokine eotaxin-1. Treatment of these mice with corticosteroids significantly reduced eosinophilia and epithelial inflammation. Conclusions L2-IL5 mice provide a novel experimental model that can potentially be used in preclinical testing of EoE-related therapeutics and mechanistic studies identifying pathogenetic features associated with mucosal eosinophilia.
Psychosocial Outcomes for Children With Nonalcoholic Fatty Liver Disease Over Time and Compared With Obese Controls
Kerkar, Nanda , D’Urso, Christine, Nostrand, Kelsey Van, Kochin, Israel, Gault, Allison, Suchy, Frederick J., Miloh, Tamir , Arnon, Ronen , Chu, Jaime , Annunziato, Rachel A.

Journal of Pediatric Gastroenterology and Nutrition | November 17, 2012 | Volume: 56 | Issue: 1 | Pages: 77-82

10.1097/mpg.0b013e31826f2b8c | PMID 22925921 Get It

ABSTRACTObjectives:Children with nonalcoholic fatty liver disease (NAFLD) experience compromised quality of life (QOL) akin to those with other chronic disease. Our objectives were to examine the association between NAFLD and QOL as well as other psychosocial outcomes, to compare psychosocial outcomes to obese children without known NAFLD, and to determine whether present standard care for NAFLD results in weight loss and improvement in psychosocial outcomes longitudinally.Methods:Children with NAFLD between 8 and 18 years and obese control children without known NAFLD were consented to complete a brief psychosocial battery examining depression (Children's Depression Inventory), QOL (Pediatric Quality of Life Inventory; PedsQL), and effect of weight on self‐esteem (Body‐Esteem Scale for Adolescents and Adults) at baseline; and additionally for the NAFLD group after at least 6 months.Results:A total of 48 children with NAFLD and 40 obese control children were enrolled. The PedsQL scores were not significantly different but the CDI total score and subscales of negative mood, ineffectiveness, and negative self‐esteem as well as all of the 3 subscales of BESAA, appearance, attribution, and weight were worse in the NAFLD group compared with obese controls. The PedsQL scores also did not change after standard care in the 33 patients with NAFLD who completed the follow‐up evaluations, but the CDI score differed between those whose body mass index improved or not.Conclusions:Children with NAFLD have higher levels of depression than obese controls. Outcomes did not improve with standard care. Larger longitudinal studies and appropriate interventions are required in this area.
Outcome Following Aminosalicylate Therapy in Children Newly Diagnosed As Having Ulcerative Colitis
Zeisler, Bella, Lerer, Trudy, Markowitz, James , Mack, David , Bousvaros, Athos, Keljo, David J., Rosh, Joel R. , Evans, Jonathan, Otley, Anthony , Kay, Marsha , Grossman, Andrew B., Saeed, Shehzad A. , Carvalho, Ryan , Oliva‐Hemker, Maria , Faubion, William A. , Sudel, Boris , Pfefferkorn, Marian, Ashai-Khan, Farhat N., LeLeiko, Neal S. , Hyams, Jeffrey S. , Griffiths, Anne Marie , Kappelman, Michael D. , Leleiko, Neal S

Journal of Pediatric Gastroenterology and Nutrition | November 17, 2012 | Volume: 56 | Issue: 1 | Pages: 12-18

10.1097/mpg.0b013e31826ac41a | PMID 22847466 Get It

ABSTRACTObjectives:Despite a paucity of published supporting data, 5‐aminosalicylate (5‐ASA) use in pediatric ulcerative colitis (UC) is common. The present study describes the use and outcome of a large multicenter inception cohort of children with UC treated with 5‐ASA.Methods:Data were obtained from the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry, a prospective North American observational study of children newly diagnosed as having inflammatory bowel disease ages 16 years or younger. Patient data are recorded at diagnosis, 30 days, and then quarterly. Patients are managed by physician dictate, not protocol. Disease activity is classified by physician global assessment. The primary outcome examined was corticosteroid (CS) free, inactive UC at 1 year following initiation of 5‐ASA within 30 days of diagnosis (with or without concomitant CS use) without the need for rescue therapy (immunomodulators, biologics, or colectomy).Results:Study subjects included 213 patients newly diagnosed as having UC who received oral 5‐ASA compounds (115 of whom also received CS) during the first 30 days after diagnosis, and no other oral therapies for the treatment of UC. Of these 213 patients, 86 (40%) were CS free and physician global assessment inactive at 1 year without rescue. Outcome was not associated with disease severity at diagnosis, demographic or laboratory factors examined, or initial dose of 5‐ASA used.Conclusions:Forty percent of children taking 5‐ASA as primary maintenance therapy at diagnosis are in CS‐free remission after 1 year of treatment. Further pediatric studies will be needed to address whether increased adherence and/or higher dosing schedules will improve outcomes.
Duodenal Intraepithelial Lymphocytosis With Normal Villous Architecture in Pediatric Patients
Shmidt, Eugenia , Smyrk, Thomas C. , Faubion, William A. , Oxentenko, Amy S.

Journal of Pediatric Gastroenterology and Nutrition | November 17, 2012 | Volume: 56 | Issue: 1 | Pages: 51-55

10.1097/mpg.0b013e318267c353 | PMID 22785416 Get It

ABSTRACTObjectives:Small bowel intraepithelial lymphocytosis (IELs) with normal villous architecture is a relatively common finding, often of uncertain significance. The aims of our study were to determine the prevalence of this finding, its clinical associations, its specificity for celiac disease (CD), and whether histologic clues exist that increase the specificity for CD in this setting, all in the pediatric population.Methods:The Mayo Clinic electronic pathology database was searched between January 1, 2000 and December 31, 2009 for patients younger than 18 years who had the terms “normal villi” and “increased intraepithelial lymphocytes” in their small bowel biopsy reports. All of the slides were reviewed to confirm the histologic findings. Demographic, serologic, pathologic, and clinical informations were obtained.Results:Among 1290 duodenal biopsies obtained from children during the years 2000 and 2009, 56 (4.3%) were noted to have “normal villous architecture with increased intraepithelial lymphocytes.” In the 54 patients not known to have CD before biopsy, 48 (89%) had serologic testing for CD. Of these 48 patients, 9 were labeled with CD, although only 5 of 9 met the definite criteria for the diagnosis, based on a combination of serologic markers, human leukocyte antigen haplotyping, and response to gluten‐free diet. No clinical features pointed to a diagnosis of CD. There was no correlation between CD and number of IELs, but patients with newly diagnosed CD were more likely to have a tip‐heavy lymphocyte distribution. Other diagnoses made during the study period and in follow‐up were inflammatory bowel disease (5), Helicobacter pylori infection (3), medication‐related injury (10), and systemic autoimmune disorders (2).Conclusions:Increased IELs with normal villous architecture in small bowel biopsies are clinically important in children, and are associated with a new definite diagnosis of CD in 9% of pediatric patients. Even at this low sensitivity, clinical work‐up for CD is mandated in all of the patients with this finding.
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer’s disease?
Mielke, Michelle M. , Haughey, Norman J. , Mielke, Michelle M

Clinical Lipidology | November 17, 2012 | Volume: 7 | Issue: 5 | Pages: 525-536

10.2217/clp.12.59 | PMID 23606909 Get It

Effects of Mutated Pregnancy-Associated Plasma Protein-A on Atherosclerotic Lesion Development in Mice
Boldt, Henning B. , Bale, Laurie K., Resch, Zachary T., Oxvig, Claus , Overgaard, Michael T. , Conover, Cheryl A.

Endocrinology | November 17, 2012 | Volume: 154 | Issue: 1 | Pages: 246-252

10.1210/en.2012-1552 | PMID 23161866 Get It

Pregnancy-associated plasma protein-A (PAPP-A) is a large multidomain metalloprotease involved in cleavage of IGF binding protein (IGFBP)-4 and -5 thereby causing release of bioactive IGF. Individual domains of PAPP-A have been characterized in vitro, including the metzincin proteolytic domain important for IGFBP proteolytic activity, short consensus repeats critical for cell surface association, and Lin-12/Notch repeat module demonstrated to determine IGFBP substrate specificity. To test the hypothesis that specific cleavage of IGFBP-4 by PAPP-A in close proximity to the cell surface is required for development of lesions in a murine model of atherosclerosis, the following PAPP-A transgenic (Tg) mice were generated: TgE483A, which lacks all PAPP-A proteolytic activity; TgD1499A, which selectively lacks proteolytic activity against IGFBP-4; and TgK1296A/K1316A, in which cell surface binding is compromised. Following cross-breeding with apolipoprotein E (ApoE) knockout (KO) mice, ApoE KO/Tg mice were fed a high-fat diet to promote aortic lesion development. Lesion area was increased 2-fold in aortas from ApoE KO/Tg wild-type compared with ApoE KO mice (P < 0.001). However, there was no significant increase in the lesion area in any of the ApoE KO/Tg mutant mice. We conclude that PAPP-A proteolytic activity is required for the lesion-promoting effect of PAPP-A and that its specificity must be directed against IGFBP-4. Furthermore, our data demonstrate that cleavage of IGFBP-4 at a distance from the cell surface, and hence from the IGF receptor, is not effective in promoting the development of the atherosclerotic lesions. Thus, PAPP-A exerts its effect while bound to the cell surface in vivo.